Connections The partnership will address global food security challenges through optimised agricultural research and data-driven innovation.
2024
connections
Connections EMBL hosted a Science Day with Evonik, bringing together 16 industry experts and EMBL scientists to explore collaborative research opportunities.
2024
connections
Science & Technology A new research paper published in Nature Communications lays the groundwork for the development of new drugs specific to genetic mutations or alterations responsible for the onset of tumours or genetic diseases.
2024
science-technology
Connections This event bridged research and entrepreneurship, fuelling innovation and discovery. Attendees immersed themselves in insightful discussions and invaluable networking opportunities, inspired to journey from lab research to entrepreneurial success.
2024
connections
Science & Technology A study from the Hackett group at EMBL Rome led to the development of an epigenetic editing system that allows to precisely program chromatin modifications at any specific position in the genome, to understand their causal role in transcription regulation.
2024
science-technology
Science & Technology Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics.
2023
sciencescience-technology
ConnectionsLab Matters Through the collaborative framework agreement, EMBL and ZEISS aim to accelerate the development of imaging technology to advance life science research.
2023
connectionslab-matters
Lab MattersPeople & Perspectives Jürgen Bauer talks about translating science into applications with societal benefit, his journey from the lab bench to business development, and technology transfer at EMBL.
2023
lab-matterspeople-perspectives
ConnectionsLab Matters One of EMBL’s core missions is the development and transfer of scientific know-how and technologies to academia, industry, and commercial entities to facilitate further research, innovations, and commercialisation for the benefit of society at large. Working across Europe, EMBL has partnerships…
2023
connectionslab-matters
ConnectionsLab Matters A new formal collaboration agreement enables will help smooth the transition from fundamental science to innovation.
2022
connectionslab-matters
Lab MattersScience & Technology Experiences at EMBL Rome led former group leader to establish his start-up in Italy, developing a new generation of gene therapies.
2022
alumnilab-mattersscience-technologytechnology-and-innovation
Lab MattersScience & Technology Florent Cipriani, who recently retired as Head of the Instrumentation Team after a long career at EMBL Grenoble, is one of the pioneers of instrumentation development in this field.
2021
lab-mattersscience-technology
Lab Matters The CrystalDirect® technology, combined with the web-based CRIMS software enable a fully automated, remote-controlled protein-to-structure pipeline.
2020
lab-matters
Lab Matters Reflecting on 20 years of EMBLEM
2019
lab-matters
Lab MattersScience & Technology New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies
2018
lab-mattersscience-technology
ConnectionsLab Matters Accelerating researchers’ access to next-generation light-sheet microscopy
2017
connectionslab-matters
ConnectionsLab Matters GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
2017
connectionslab-matters
Science & Technology From initial development to a start-up company: Selective Plane Illumination Microscopy (SPIM) at EMBL.
2015
sciencescience-technology
Lab MattersScience & Technology A microscopy technique is poised to shine new light on biological questions: as sheets of light can scan everything from developing embryos to single cells or functioning brains, a technique called light-sheet microscopy is gaining traction. It enables scientists to observe living cells in three…
2015
lab-mattersscience-technology
Connections A novel high-tech microscope will be brought to the marketplace, giving laboratories everywhere fascinating new insights into living organisms. EMBLEM Technology Transfer GmbH (EMBLEM), the commercial entity of the European Molecular Biology Laboratory (EMBL), announced today that it has signed a…
2005
connections
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive
